Overview
Madison Lord is a primary care provider, practicing in Internal Medicine in Newark, Delaware. Dr. Lord is rated as an Experienced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). Her top area of expertise is Mantle Cell Lymphoma (MCL).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
4755 Ogletown Stanton Rd, Newark, DE 19718
Medical Oncology Hematology Consultants
Jamal Misleh is a Hematologist and an Internal Medicine provider in Middletown, Delaware. Dr. Misleh is rated as a Distinguished provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Neuroendocrine Tumor, Bone Marrow Aspiration, and Bone Marrow Transplant.
Christopher Melani is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Melani is rated as a Distinguished provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Lymphomatoid Granulomatosis, Primary Mediastinal B-Cell Lymphoma (PMBCL), B-Cell Lymphoma, and Non-Hodgkin Lymphoma.
Partnermd Maryland PC
Ellie Goldbloom is a primary care provider, practicing in Internal Medicine in Owings Mills, Maryland. Dr. Goldbloom is rated as an Experienced provider by MediFind in the treatment of Mantle Cell Lymphoma (MCL). Her top areas of expertise are Sitosterolemia, Mantle Cell Lymphoma (MCL), Subacute Combined Degeneration, and Childhood Iron Deficiency Anemia. Dr. Goldbloom is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Mantle Cell Lymphoma (MCL)Dr. Lord isExperienced. Learn about Mantle Cell Lymphoma (MCL).
